3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Advance Provision of Mifepristone and Misoprostol via Online Telemedicine in the US

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This cross-sectional study examines trends in the demand and characteristics and motivations of individuals who requested advance provision of abortion medications.

          Related collections

          Most cited references4

          • Record: found
          • Abstract: found
          • Article: not found
          Is Open Access

          Support for and interest in alternative models of medication abortion provision among a national probability sample of U.S. women

          The objective was to assess women's personal interest in and support for three alternative models of medication abortion (MA) provision.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Making the case for advance provision of mifepristone and misoprostol for abortion in the United States

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Interest in advance provision of abortion pills: a national survey of potential users in the USA

              Objective To assess interest in clinician-administered advance provision of abortion pills among potential users in the USA. Methods Using social media advertisements, we recruited people living in the USA who were aged 18–45 years and assigned female at birth, who were not pregnant or planning pregnancy, for an online survey on reproductive health experiences and attitudes. We explored interest in advance provision of abortion pills, participant characteristics, including demographics and pregnancy history, contraceptive use, abortion knowledge and comfort, and healthcare system distrust. We used descriptive statistics to assess interest in advance provision, and ordinal regression modelling to evaluate differences in interest controlling for age, pregnancy history, contraceptive use, familiarity and comfort with medication abortion, and healthcare system distrust, reporting adjusted odds ratios (aORs) and 95% confidence intervals (95% CIs). Results From January-February 2022, we recruited 634 diverse respondents from 48 states, among whom 65% were interested, 12% neutral, and 23% disinterested in advance provision. There were no differences among interest groups by US region, race/ethnicity, or income. In the model, variables associated with interest included being aged 18–24 years (aOR 1.9, 95% CI 1.0 to 3.4) versus 35–45 years, using a tier 1 (permanent or long-acting reversible) or tier 2 (short-acting hormonal) contraceptive method (aOR 2.3, 95% CI 1.2 to 4.1, and aOR 2.2, 95% CI 1.2 to 3.9, respectively) versus no contraception, being familiar or comfortable with the medication abortion process (aOR 4.2, 95% CI 2.8 to 6.2, and aOR 17.1, 95% CI 10.0 to 29.0, respectively), and having high healthcare system distrust (aOR 2.2, 95% CI 1.0 to 4.4) versus low distrust. Conclusion As abortion access becomes more constrained, strategies are needed to ensure timely access. Advance provision is of interest to the majority of those surveyed and warrants further policy and logistical exploration.
                Bookmark

                Author and article information

                Journal
                JAMA Internal Medicine
                JAMA Intern Med
                American Medical Association (AMA)
                2168-6106
                January 02 2024
                Affiliations
                [1 ]LBJ School of Public Affairs, University of Texas at Austin, Austin
                [2 ]Mathematica Inc, Cambridge, Massachusetts
                [3 ]Vrije Universiteit, Amsterdam, the Netherlands
                [4 ]Aid Access, Amsterdam, the Netherlands
                Article
                10.1001/jamainternmed.2023.7291
                0f49a648-b7b7-4fd2-b3a2-967f847e2f36
                © 2024
                History

                Comments

                Comment on this article